The C-terminal domain of connexin43 modulates cartilage structure via chondrocyte phenotypic changes
Metrics: PDF 1276 views | HTML 1872 views | ?
Raquel Gago-Fuentes1, John F. Bechberger2, Marta Varela-Eirin1, Adrian Varela-Vazquez1, Benigno Acea1, Eduardo Fonseca1, Christian C. Naus2,*, Maria D. Mayan1,*
1CellCOM-SB Research Group, Instituto de Investigación Biomédica de A Coruña (INIBIC), CH-Universitario A Coruña (XXIAC), University of A Coruña, Servizo Galego de Saúde (SERGAS), 15006 A Coruña, Spain
2Department of Cellular and Physiological Sciences, The Life Sciences Institute, University of British Columbia, V6T 1Z3 Vancouver, British Columbia, Canada
*Shared senior authors
Maria D. Mayan, email: Ma.Dolores.Mayan.Santos@sergas.es
Keywords: articular cartilage, connexin43, chondrocyte, osteoarthritis, C-terminal domain of Cx43
Received: June 07, 2016 Accepted: September 16, 2016 Published: September 22, 2016
Chondrocytes in cartilage and bone cells population express connexin43 (Cx43) and gap junction intercellular communication (GJIC) is essential to synchronize cells for coordinated electrical, mechanical, metabolic and chemical communication in both tissues. Reduced Cx43 connectivity decreases chondrocyte differentiation and defective Cx43 causes skeletal defects. The carboxy terminal domain (CTD) of Cx43 is located in the cytoplasmic side and is key for protein functions. Here we demonstrated that chondrocytes from the CTD-deficient mice, K258stop/Cx43KO and K258stop/K258stop, have reduced GJIC, increased rates of proliferation and reduced expression of collagen type II and proteoglycans. We observed that CTD-truncated mice were significantly smaller in size. Together these results demonstrated that the deletion of the CTD negatively impacts cartilage structure and normal chondrocyte phenotype. These findings suggest that the proteolytic cleavage of the CTD under pathological conditions, such as under the activation of metalloproteinases during tissue injury or inflammation, may account for the deleterious effects of Cx43 in cartilage and bone disorders such as osteoarthritis.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.